Antag Therapeutics secures €80 million Series A financing
Funds to advance AT-7687 and expand obesity treatment pipeline
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Novo Holdings
Pharma CMO M&A activity shifts focus to scaling in 2023: GlobalData
High inflation and interest rates along with an uncertain business environment have disincentivised investment. The focus shifts…
Novo Holdings co-leads £90 million Series A financing for Myricx Bio
The funds will be used to build out Myricx Bio’s proprietary payload platform and advance its pipeline through clinical proof of…
Catalent to help Novo Nordisk address production demands for Ozempic and Wegovy: GlobalData
The acquisition of Catalent by Novo Holdings expects to see three new manufacturing sites added to Novo Nordisk’s arsenal, to…
Novo Holdings Repair Impact Fund supports MinervaX EUR 72 million financing to develop vaccine…
Novo Holdings made the initial investment in MinervaX in 2014 and remains its largest shareholder